Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
RXRX · against 413 other Healthcare companies of similar size
Ranked #148 of 414 · scores higher than 64% of peers · safety percentile 67
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)44 peers with a safety percentile of 60–69, including RXRX · Click a bar to see the companies
Mainly thanks to its current ratio and debt / equity, which are stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | RXRX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 393 reported | 0.07× | 0.22× | 71% | 33% | |
| BetaLower is better · 390 reported | 1.07 | 0.55 | 22% | 33% | |
| Current ratioHigher is better · 399 reported | 5.03× | 2.89× | 70% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.5B USD | 100 | 44 | |
| 2 | 1.2B USD | 100 | 40 | |
| 3 | 2.6B USD | 100 | 43 | |
| 4 | 1.1B USD | 100 | ||
| 5 | 3.6B USD | 99 | ||
| 144 | 232.9B JPY (≈$1.6B) | 68 | 20 | |
| 145 | 1.7B USD | 68 | 46 | |
| 146 | 217.6B INR (≈$2.6B) | 68 | 67 | |
| 147 | 204.5B JPY (≈$1.4B) | 68 | 71 | |
| 148 | 2.0B USD | 67 | 24 | |
| 149 | 26.6B CNY (≈$3.7B) | 67 | 67 | |
| 150 | 19.7B HKD (≈$2.5B) | 67 | 84 | |
| 151 | 14.2B HKD (≈$1.8B) | 67 | 64 | |
| 152 | 22.4B CNY (≈$3.1B) | 67 | 62 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score